Alodokter
PrivateLast Round
Angel
Sep 18, 2025
Total Funding Raised
$59.3M
Company Overview
Alodokter operates in Healthcare & Life Sciences and is based in Indonesia. Its latest recorded funding round was an Angel round in September 2025.
Alodokter is a healthtech company that provides an integrated digital healthcare platform offering telemedicine, doctor appointment booking, medical content, and health insurance services.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, E-commerce, InsurTech, Digital Publishing
Business Model
B2C
Customer Profile
Subscription SaaS, Freemium, Marketplace Commission, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alodokter Comparables
Compare Alodokter with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Halodoc | 92% | |
| SehatQ | 92% | |
| Good Doctor Technology | 87% |
For institutional investors. Book with your work email.
Alodokter Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Sep 18, 2025 | ||||
| Series C Extension | Feb 21, 2024 | ||||
| Early Funding | Jul 5, 2023 | ||||
| Series C Extension | Sep 29, 2022 | ||||
| Early Funding | Jun 7, 2021 | ||||
Series C Extension | Nov 12, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Alodokter Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Heritas Capital Management | Series C, Series C Extension |
| FengHe Fund Management Pte. Ltd. | Series B |
| AngelCentral | Angel |
| Singapore Health Management | Series C |
| DAYLI Partners | Series C |
| Golden Gate Ventures | Seed, Series B, Series C, Series C Extension, Series A |
| Hera Capital | Series C Extension, Series C, Early Funding |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 29, 2022
$3M round led by Beacon Venture Capital and Samsung Venture Investment.
- Oct 16, 2019
$33M round led by Sequis Life.
For institutional investors. Book with your work email.
Alodokter Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Alodokter's valuation, stock price, and market status.
Is Alodokter a public or private company?
Alodokter is a private company.
What is the current stock price of Alodokter?
Alodokter is a private company, so its shares have no public market price. Caplight tracks Alodokter's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alodokter worth (valuation)?
Valuation information for Alodokter is not publicly available.
Can I buy Alodokter stock?
Alodokter shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alodokter's last funding round?
Alodokter's most recent funding round was Angel on September 18, 2025.
Who are the main investors in Alodokter?
Key investors in Alodokter include AngelCentral, Golden Gate Ventures, SBVA, Fenox Venture Capital, Samsung Venture Investment.
Will Alodokter IPO soon?
No public IPO plans have been announced for Alodokter.
How can I track Alodokter secondary market activity?
Caplight tracks bids, offers, and trades in Alodokter's shares on secondary markets.